Your browser doesn't support javascript.
loading
Data compatibility in the addiction sciences: an examination of measure commonality.
Conway, Kevin P; Vullo, Genevieve C; Kennedy, Ashley P; Finger, Matthew S; Agrawal, Arpana; Bjork, James M; Farrer, Lindsay A; Hancock, Dana B; Hussong, Andrea; Wakim, Paul; Huggins, Wayne; Hendershot, Tabitha; Nettles, Destiney S; Pratt, Joseph; Maiese, Deborah; Junkins, Heather A; Ramos, Erin M; Strader, Lisa C; Hamilton, Carol M; Sher, Kenneth J.
Afiliação
  • Conway KP; Division of Epidemiology, Services, and Prevention Research, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, United States. Electronic address: kconway@nida.nih.gov.
  • Vullo GC; Division of Epidemiology, Services, and Prevention Research, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, United States; Kelly Government Solutions, Bethesda, MD, United States.
  • Kennedy AP; Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, United States.
  • Finger MS; Division of Epidemiology, Services, and Prevention Research, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, United States.
  • Agrawal A; Washington University in St. Louis, St. Louis, MO, United States.
  • Bjork JM; Division of Clinical Neuroscience and Behavioral Research, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, United States.
  • Farrer LA; Boston University, Boston, MA, United States.
  • Hancock DB; RTI International, Research Triangle Park, NC, United States.
  • Hussong A; University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Wakim P; Center for the Clinical Trials Network, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, United States.
  • Huggins W; RTI International, Research Triangle Park, NC, United States.
  • Hendershot T; RTI International, Research Triangle Park, NC, United States.
  • Nettles DS; RTI International, Research Triangle Park, NC, United States.
  • Pratt J; RTI International, Research Triangle Park, NC, United States.
  • Maiese D; RTI International, Research Triangle Park, NC, United States.
  • Junkins HA; National Human Genome Research Institute, Bethesda, MD, United States.
  • Ramos EM; National Human Genome Research Institute, Bethesda, MD, United States.
  • Strader LC; RTI International, Research Triangle Park, NC, United States.
  • Hamilton CM; RTI International, Research Triangle Park, NC, United States.
  • Sher KJ; University of Missouri, Columbia, MO, United States.
Drug Alcohol Depend ; 141: 153-8, 2014 Aug 01.
Article em En | MEDLINE | ID: mdl-24954640
ABSTRACT
The need for comprehensive analysis to compare and combine data across multiple studies in order to validate and extend results is widely recognized. This paper aims to assess the extent of data compatibility in the substance abuse and addiction (SAA) sciences through an examination of measure commonality, defined as the use of similar measures, across grants funded by the National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA). Data were extracted from applications of funded, active grants involving human-subjects research in four scientific areas (epidemiology, prevention, services, and treatment) and six frequently assessed scientific domains. A total of 548 distinct measures were cited across 141 randomly sampled applications. Commonality, as assessed by density (range of 0-1) of shared measurement, was examined. Results showed that commonality was low and varied by domain/area. Commonality was most prominent for (1) diagnostic interviews (structured and semi-structured) for substance use disorders and psychopathology (density of 0.88), followed by (2) scales to assess dimensions of substance use problems and disorders (0.70), (3) scales to assess dimensions of affect and psychopathology (0.69), (4) measures of substance use quantity and frequency (0.62), (5) measures of personality traits (0.40), and (6) assessments of cognitive/neurologic ability (0.22). The areas of prevention (density of 0.41) and treatment (0.42) had greater commonality than epidemiology (0.36) and services (0.32). To address the lack of measure commonality, NIDA and its scientific partners recommend and provide common measures for SAA researchers within the PhenX Toolkit.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa / Comportamento Aditivo / Transtornos Relacionados ao Uso de Substâncias Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa / Comportamento Aditivo / Transtornos Relacionados ao Uso de Substâncias Idioma: En Ano de publicação: 2014 Tipo de documento: Article